These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 31599484

  • 1. Management of coexistent neurogenic orthostatic hypotension and supine hypertension.
    Cannom DS.
    J Clin Hypertens (Greenwich); 2019 Nov; 21(11):1732-1734. PubMed ID: 31599484
    [No Abstract] [Full Text] [Related]

  • 2. Standing and Supine Blood Pressure Outcomes Associated With Droxidopa and Midodrine in Patients With Neurogenic Orthostatic Hypotension: A Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials.
    Chen JJ, Han Y, Tang J, Portillo I, Hauser RA, Dashtipour K.
    Ann Pharmacother; 2018 Dec; 52(12):1182-1194. PubMed ID: 29972032
    [Abstract] [Full Text] [Related]

  • 3. Adjusting droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease.
    Goodman BP, Claassen D, Mehdirad A.
    Clin Auton Res; 2017 Jul; 27(Suppl 1):17-19. PubMed ID: 28631223
    [No Abstract] [Full Text] [Related]

  • 4. Diagnosing and treating neurogenic orthostatic hypotension in primary care.
    Kuritzky L, Espay AJ, Gelblum J, Payne R, Dietrich E.
    Postgrad Med; 2015 Jul; 127(7):702-15. PubMed ID: 26012731
    [Abstract] [Full Text] [Related]

  • 5. Defining successful treatment of neurogenic orthostatic hypotension with droxidopa in a patient with multiple system atrophy.
    Goodman BP, Gupta F.
    Clin Auton Res; 2017 Jul; 27(Suppl 1):21-23. PubMed ID: 28631222
    [No Abstract] [Full Text] [Related]

  • 6. Titrating droxidopa to maximize symptomatic benefit in a patient with Parkinson disease and neurogenic orthostatic hypotension.
    Gupta F, Karabin B, Mehdirad A.
    Clin Auton Res; 2017 Jul; 27(Suppl 1):15-16. PubMed ID: 28699047
    [No Abstract] [Full Text] [Related]

  • 7. Neurogenic orthostatic hypotension in Parkinson's disease: evaluation, management, and emerging role of droxidopa.
    Isaacson SH, Skettini J.
    Vasc Health Risk Manag; 2014 Jul; 10():169-76. PubMed ID: 24729712
    [Abstract] [Full Text] [Related]

  • 8. Supine hypertension during general anesthesia in a patient taking midodrine.
    Chaimberg KH, Travis KW.
    Anesth Analg; 2002 Nov; 95(5):1196-7, table of contents. PubMed ID: 12401592
    [Abstract] [Full Text] [Related]

  • 9. Orthostatic hypotension: pathophysiology, assessment, treatment and the paradox of supine hypertension.
    Chisholm P, Anpalahan M.
    Intern Med J; 2017 Apr; 47(4):370-379. PubMed ID: 27389479
    [Abstract] [Full Text] [Related]

  • 10. New developments in the management of neurogenic orthostatic hypotension.
    Biaggioni I.
    Curr Cardiol Rep; 2014 Nov; 16(11):542. PubMed ID: 25303896
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of Servo-Controlled Splanchnic Venous Compression in the Treatment of Orthostatic Hypotension: A Randomized Comparison With Midodrine.
    Okamoto LE, Diedrich A, Baudenbacher FJ, Harder R, Whitfield JS, Iqbal F, Gamboa A, Shibao CA, Black BK, Raj SR, Robertson D, Biaggioni I.
    Hypertension; 2016 Aug; 68(2):418-26. PubMed ID: 27271310
    [Abstract] [Full Text] [Related]

  • 12. Managing supine hypertension in a patient with non-diabetic autonomic neuropathy receiving droxidopa for neurogenic orthostatic hypotension.
    Vernino S, Lew M, Kremens D.
    Clin Auton Res; 2017 Jul; 27(Suppl 1):35-37. PubMed ID: 28623420
    [No Abstract] [Full Text] [Related]

  • 13. Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease.
    Kremens D, Lew M, Claassen D, Goodman BP.
    Clin Auton Res; 2017 Jul; 27(Suppl 1):29-31. PubMed ID: 28674867
    [No Abstract] [Full Text] [Related]

  • 14. Management Strategies for Comorbid Supine Hypertension in Patients with Neurogenic Orthostatic Hypotension.
    Isaacson SH, Dashtipour K, Mehdirad AA, Peltier AC.
    Curr Neurol Neurosci Rep; 2021 Mar 09; 21(4):18. PubMed ID: 33687577
    [Abstract] [Full Text] [Related]

  • 15. Delayed orthostatic hypotension and vasovagal syncope: a diagnostic dilemma.
    Fedorowski A, van Wijnen VK, Wieling W.
    Clin Auton Res; 2017 Aug 09; 27(4):289-291. PubMed ID: 28550504
    [No Abstract] [Full Text] [Related]

  • 16. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension.
    Gibbons CH, Schmidt P, Biaggioni I, Frazier-Mills C, Freeman R, Isaacson S, Karabin B, Kuritzky L, Lew M, Low P, Mehdirad A, Raj SR, Vernino S, Kaufmann H.
    J Neurol; 2017 Aug 09; 264(8):1567-1582. PubMed ID: 28050656
    [Abstract] [Full Text] [Related]

  • 17. Caudate hemorrhage as a possible complication of midodrine-induced supine hypertension.
    Sandroni P, Benarroch EE, Wijdicks EF.
    Mayo Clin Proc; 2001 Dec 09; 76(12):1275. PubMed ID: 11761508
    [No Abstract] [Full Text] [Related]

  • 18. Orthostatic Hypotension in Parkinson Disease.
    Palma JA, Kaufmann H.
    Clin Geriatr Med; 2020 Feb 09; 36(1):53-67. PubMed ID: 31733702
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of single or combined midodrine and pyridostigmine in orthostatic hypotension.
    Byun JI, Moon J, Kim DY, Shin H, Sunwoo JS, Lim JA, Kim TJ, Lee WJ, Lee HS, Jun JS, Park KI, Lee ST, Jung KH, Jung KY, Lee SK, Chu K.
    Neurology; 2017 Sep 05; 89(10):1078-1086. PubMed ID: 28794253
    [Abstract] [Full Text] [Related]

  • 20. Prevention and Management of Supine Hypertension in Patients With Orthostatic Hypotension.
    Moroi MK, Ruzieh M, Ahmed A, Kanjwal S, Kanjwal K.
    Am J Ther; 2017 Sep 05; 28(2):e228-e231. PubMed ID: 31524637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.